Method for the indentification of animals vaccinated against brucella
Fecha
2011-06-09
Autores
Grilló, María Jesús
Amorena Zabalza, Beatriz
de Andrés Cara, Damián
Moreno, Edgardo
Chaves-Olarte, Esteban
Guzman-Verri, Caterina
Chacón Diaz, Carlos
Título de la revista
ISSN de la revista
Título del volumen
Editor
European Patent Application
Resumen
La presente invención se refiere al uso de una cepa de Brucella spp. que expresa la proteína Green Flourescent Protein (GFP) en la elaboración de medicamentos para la prevención de la brucelosis en mamíferos, a las vacunas frente a la brucelosis, y al método para la identificación de los mamíferos a los que se les ha administrado dichas vacunas. Preferiblemente, el método de la invención es un inmunoensayo, y aún más preferiblemente es un ensayo inmunoabsorbente ligado a enzimas (ELISA).
The present invention relates to: the use of a strain of Brucella spp. expressing the green fluorescent protein (GFP) in the preparation of medicaments for the prevention of brucellosis in mammals, vaccines against brucellosis, and the method for identifYing mammals to which said vaccines have been administered. Preferably, the method of the invention is an immunoassay, and, more preferably, it is an enzyme-linked immunosorbent assay (ELISA).
The present invention relates to: the use of a strain of Brucella spp. expressing the green fluorescent protein (GFP) in the preparation of medicaments for the prevention of brucellosis in mammals, vaccines against brucellosis, and the method for identifYing mammals to which said vaccines have been administered. Preferably, the method of the invention is an immunoassay, and, more preferably, it is an enzyme-linked immunosorbent assay (ELISA).
Descripción
Palabras clave
BRUCELOSIS, BRUCELLA, ELISA, VACUNA, VACCINES, MAMIFEROS, MAMMALS